Adlon Therapeutics gets FDA green light for Adhansia XR capsulesAdlon Therapeutics' Adhansia XR capsules offer a new option for ADHD patients. Alkem gets FDA nod for generic DiovanAlkem's generic Diovan is expected to help relieve a recent shortage of valsartan. FDA approves new indication for Regeneron, Sanofi’s Dupixent The FDA has approved a new indication for Dupixent, providing an option for patients age 12-to-17 years old with moderate to severe atopic dermatitis. Pharma Logistics inks partnership with GSPO’s Co-op Power buying group Members of Co-op Power, the group purchasing organization of Garden State Pharmacy Owners, will have access to Pharma Logistics' onsite and box and ship services. Pfizer’s Herceptin biosimilar Trazimera gets FDA nod Pfizer's Trazimera provides treatment for HER2 breast and gastric cancers. Amneal introduces generic Exelon Patch The rivastigmine transdermal system had a market value of approximately $214 million for the 12 months ended January 2019. AAM raises concern over Trump budget's potential exclusivity changes The Association for Accessible Medicines criticized the Administration's proposal to amend the 180-day period of exclusivity for first generics. Cynthia Schwalm to join Hikma's board Cynthia Schwalm, who has held positions at Ipsen, Eisai, Amgen and J&J, is joining Hikma's board June 1. Lannett to distribute generic Adderall Adderall, including generic versions, had a market value of about $361 million for the 12 months ended January 2019, Lannett said. Teva introduces authorized generic Flector Patch The Flector Patch has a market value of roughly $123 million. First Previous 531 532 533 534 535 Next Last
